- Company Directors - C
- Caudill Randall L W
Insider Trading History of Caudill Randall L W
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Caudill Randall L W since 2005.
The trader's CIK number is 1217417.
At the time of the last reporting, Caudill Randall L W was the Director of Scolr Pharma, Inc.. (stock ticker symbol DDD).
Also see all insider trading activities at Scolr Pharma, Inc..
Note that in the past
CAUDILL RANDALL L W also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Scolr Pharma, Inc. (DDD) by Caudill Randall L W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | DDD | 0 | $0 | 39,526 | $39,526 | 0 | $0 |
| 2005 | DDD | 1,000 | $3,850 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Vaxgen Inc (VXGN) by Caudill Randall L W
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | VXGN | 10,000 | $6,500 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Caudill Randall L W:
1. Scolr Pharma, Inc. (DDD)
2. Vaxgen Inc (VXGN)
Table 1. Insider trading of Scolr Pharma, Inc. (DDD) by Caudill Randall L W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-03-11 | DDD | Sale | 39,526 | 1.00 | 39,526 |
| 2005-04-08 | DDD | Buy | 1,000 | 3.85 | 3,850 |
Table 2. Insider trading of Vaxgen Inc (VXGN) by Caudill Randall L W
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-11-16 | VXGN | Buy | 10,000 | .65 | 6,500 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Caudill Randall L W
(Director of Scolr Pharma, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.